Videos

Explore safer IBS treatment choices for primary care: lifestyle steps and newer diarrhea/constipation meds beyond antidepressants and opioids.

Are preventive services falling through the cracks in diabetes care? Why role confusion across providers matters for PCPs.

A sweeping review finds women with diabetes consistently miss key preventive and reproductive services—contraception, preconception counseling, cancer and STI screening—worldwide.

Experts weigh antidepressants for IBS: small but serious mortality risk, while FDA-approved IBS drugs show stronger trials and long-term safety.

Explore monthly GLP‑1 dose titration, unusual strength jumps, and color‑coded pills—plus tips for switching safely from injectable regimens.

FDA approves orforglipron, a once-daily oral GLP‑1 for weight management, taken with food or coffee—simplifying obesity treatment.

New evidence suggests lowering LDL-C to 44 mg/dL with PCSK9 therapy may better protect high-risk patients with diabetes, aligning primary prevention targets with secondary prevention.

In the final episode, ‘Key Takeaways in Colorectal Cancer Screening,’ the faculty emphasize that while colonoscopy remains the gold standard, noninvasive stool-based tests are appropriate alternatives for average-risk patients who decline invasive screening.

In ‘Coordinating Care After Abnormal Colorectal Cancer Screening Results,’ the expert faculty focus on the critical importance of timely follow-up after a positive colorectal cancer screening test.

Once-weekly insulin makes injections simpler, boosts adherence, and lets clinics train patients fast—ideal for older adults.

ACC 2026: A new secondary analysis of the VESALIUS-CV study shows evolocumab cuts heart attacks, strokes and deaths in high‑risk patients with type 2 diabetes.

Which patients are most likely to benefit from once-weekly insulin? Early insights on insulin icodec for adults with type 2 diabetes, here.

In this episode, ‘Addressing Access Barriers in Colorectal Cancer Screening,’ the panelists explore common patient concerns about the cost of colonoscopy following a positive colorectal cancer screening test.

This episode, titled ‘Individualizing When to Stop Colorectal Cancer Screening,’ examines the nuanced decision-making involved in determining when to discontinue colorectal cancer screening.

Dr Bhatt emphasizes that clinical targets for biological variables like blood pressure and LDL-C are crucial for effective patient care.

In ‘Overcoming Barriers and Advancing Precision in Colorectal Cancer Screening,’ our experts delve into the ongoing challenges and future directions in colorectal cancer screening implementation.

In this episode, ‘Comparing Colorectal Cancer Screening Test Performance and Prep Options,’ the panelists review the performance characteristics of available colorectal cancer screening modalities, including colonoscopy, FIT, multi-target stool DNA, RNA-based tests, and blood-based assays.

Linda Stein Gold, MD, discusses recognizing when psoriasis patients need systemic therapy, and how icotrokinra's once-daily oral dosing can change the conversation.

Expert discussion on how updated guidelines

Gerontological GSA and AAFP explain digital cognitive tests for Alzheimer/dementia, EHR-ready, repeatable, supports KAER care in primary care.

AHA-style dyslipidemia update from Johns Hopkins: test Lp(a) once, then target LDL-C goals to cut cardiovascular risk and cholesterol.

Expert discussion on how updated guidelines intersect with state vaccination requirements for school entry.

Expert discussion on how vaccine education continues to play a significant role in immunization uptake and improving health equity.

Doctors warn recent vaccine policy shifts may leave infants and underserved kids unprotected, raising RSV and measles risks and widening disparities.

Experts discuss the potential unintended consequences of less children getting immunized if the current trends continue.

Genevieve Neal-Perry, MD, PhD, outlines unmet needs in managing vasomotor symptoms among African American women and discusses how elinzanetant (Lynkuet) may help shape more equitable care.

In ’Shared Decision-Making in Colorectal Cancer Screening’, the panelists focus on practical strategies for engaging patients in colorectal cancer screening conversations and improving screening uptake.

In ’Shared Decision-Making in Colorectal Cancer Screening’, the panelists focus on practical strategies for engaging patients in colorectal cancer screening conversations and improving screening uptake.

ACP explores disability inclusion in medicine: fight ableism, use ADA accommodations in residency, and strengthen diversity in the medical field.